Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04257578
Title Acalabrutinib and Anti-CD19 CAR T-cell Therapy for the Treatment of B-cell Lymphoma
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors University of Washington
Indications

diffuse large B-cell lymphoma

B-cell lymphoma

primary mediastinal B-cell lymphoma

Therapies

Acalabrutinib + axicabtagene ciloleucel

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.